Image

    Anti-Androgens May Protect Against Severe COVID-19 Outcomes: Results From a Prospective Cohort Study of 77 Hospitalized Men

    Andy Goren, Carlos Gustavo Wambier, Sabina Herrera … Rodney Sinclair
    Studysummary Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men Cell Stem Cell · 2020
    2. Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign' Journal of The American Academy of Dermatology · 2020
    3. Androgen Sensitivity Gateway to COVID-19 Disease Severity Drug Development Research · 2020

    Related research 1

    1. Androgenetic Alopecia in Women and Men Is Not Related to COVID-19 Infection Severity: A Prospective Cohort Study of Hospitalized COVID-19 Patients Journal of The European Academy of Dermatology and Venereology · 2021